BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 10452990)

  • 1. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
    Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
    J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-4 inhibits mouse mast cell Fc epsilonRI expression through a STAT6-dependent mechanism.
    Ryan JJ; DeSimone S; Klisch G; Shelburne C; McReynolds LJ; Han K; Kovacs R; Mirmonsef P; Huff TF
    J Immunol; 1998 Dec; 161(12):6915-23. PubMed ID: 9862725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP-1 regulates STAT6 phosphorylation and IL-4-mediated function in a cell type-specific manner.
    Huang Z; Coleman JM; Su Y; Mann M; Ryan J; Shultz LD; Huang H
    Cytokine; 2005 Feb; 29(3):118-24. PubMed ID: 15613279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells.
    White ED; Andrews RP; Hershey GK
    J Leukoc Biol; 2001 May; 69(5):825-30. PubMed ID: 11358992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation.
    Mekori YA; Metcalfe DD
    J Immunol; 1994 Sep; 153(5):2194-203. PubMed ID: 7519644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
    Mekori YA; Oh CK; Metcalfe DD
    J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells.
    Suzuki K; Nakajima H; Ikeda K; Maezawa Y; Suto A; Takatori H; Saito Y; Iwamoto I
    J Exp Med; 2003 Dec; 198(11):1717-27. PubMed ID: 14638848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.
    Sillaber C; Strobl H; Bevec D; Ashman LK; Butterfield JH; Lechner K; Maurer D; Bettelheim P; Valent P
    J Immunol; 1991 Dec; 147(12):4224-8. PubMed ID: 1721642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10 induces apoptosis in developing mast cells and macrophages.
    Bailey DP; Kashyap M; Bouton LA; Murray PJ; Ryan JJ
    J Leukoc Biol; 2006 Sep; 80(3):581-9. PubMed ID: 16829633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells.
    Chiba N; Masuda A; Yoshikai Y; Matsuguchi T
    J Cell Physiol; 2007 Oct; 213(1):126-36. PubMed ID: 17458900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
    Samayawardhena LA; Hu J; Stein PL; Craig AW
    Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms.
    Levings MK; Schrader JW
    J Immunol; 1999 May; 162(9):5224-9. PubMed ID: 10227996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 preferentially activates a novel STAT6 isoform in mast cells.
    Sherman MA; Secor VH; Brown MA
    J Immunol; 1999 Mar; 162(5):2703-8. PubMed ID: 10072514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3.
    Smith TJ; Ducharme LA; Weis JH
    Eur J Immunol; 1994 Apr; 24(4):822-6. PubMed ID: 7512032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells.
    Ryan JJ; Huang H; McReynolds LJ; Shelburne C; Hu-Li J; Huff TF; Paul WE
    Exp Hematol; 1997 Apr; 25(4):357-62. PubMed ID: 9131012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression.
    Heath VL; Murphy EE; Crain C; Tomlinson MG; O'Garra A
    Eur J Immunol; 2000 Sep; 30(9):2639-49. PubMed ID: 11009098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
    Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB
    Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4-triggered, STAT6-dependent production of a factor that induces mouse mast cell apoptosis.
    Hu ZQ; Zhao WH; Shimamura T; Galli SJ
    Eur J Immunol; 2006 May; 36(5):1275-84. PubMed ID: 16598817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The early growth response factor-1 contributes to interleukin-13 production by mast cells in response to stem cell factor stimulation.
    Li B; Berman J; Wu P; Liu F; Tang JT; Lin TJ
    J Immunotoxicol; 2008 Apr; 5(2):163-71. PubMed ID: 18569387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
    Shivakrupa R; Bernstein A; Watring N; Linnekin D
    Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.